Clinical efficacy of microwave ablation for the treatment of hepatic metastases

秦辉,葛勇胜,许戈良,马金良,荚卫东,余继海,张传海,刘文斌

DOI: https://doi.org/10.19405/j.cnki.issn1000-1492.2016.06.018

2016-01-01

Abstract:Objective To explore therapeutic results of local microwave ablation ( MWA) for hepatic metastasis and the factors influencing the survival after microwave therapy .Methods The clinical data of 47 patients (73 liver metastatic lesions) with metastasis hepatic carcinoma who received MWA were retrospectively analyzed.Of the 47 patients , 16 were with liver metastasis from colonic cancer , 9 with liver metastasis from rectal cancer , 14 with liver metastasis from gastric cancer , and 8 with liver metastasis from other cancers.The diameter of the metastasis lesion ranged from 1.5~13.0(6.2 ±3.5) cm.Complete ablation rate , local and distant recurrence rate and survival rate were evaluated respectively .Patients were followed up via phone call and out-patient examination .Survival analysis was evaluated by the Kaplan-Meier method , and the differences between survival rates were ascertained using the Log-rank test.Significant variables from the univariate analysis were included in the multivariate analysis , which was performed using the Cox proportional hazards model .Results The complete ablation ( CA) rate which was used to evaluate the local therapeutic effects was 89.0%,with 100.0%,92.0%and 76.9%in a diameter of lesions≤3.0 cm, 3.0~5.0 cm and 5.0 cm respectively.The CA rate was lower in the group of a diameter of lesions >5.0 cm as compared with two other groups (P<0.05).The local recurrence rate was 15.4%,with 4.5%,13.0%and 30.0%in a diameter of lesions≤3.0 cm, 3.0~5.0 cm and 5.0 cm respectively .The new intrahepatic distant re-currence rate was 42.5%.The follow-up time after MWA was 1~36(25.1 ±8.2) months.During the follow-up period, 1 year, 2 year and 3 year cumulative survival rates were 74.5%, 48.9%and 27.7%respectively , with a median survival time of 20.0 months.Univariate analysis of prognostic factors indicated that tumor size , number of metastases, tumor cell differentiation and primary site of tumors had significant prognostic influence on overall sur -vival , while age , sex and status of metastasis were not significant prognostic factors .Furthermore , multivariate sur-vival analysis revealed that only a number of metastases and primary site of tumors were identified as independent predictors of poor prognosis for hepatic metastases patients .Conclusion MWA treatment offers satisfactory local tumoricidal efficacy to liver metastasis from single lesion of colorectal carcinoma and the patients with recurrence and new metastases can be therapy repeatedly to improve long-term survival and survival quality .